Cargando…

Escherichia coli bloodstream infection preceding the diagnosis of rectal carcinoma

BACKGROUND: Cancer is one of the major comorbidities in patients with sepsis, and conversely, bloodstream infections (BSI) may precede the diagnosis of colorectal malignancy, in particular when Streptococcus gallolyticus is isolated. We present the rare case of an Escherichia coli BSI preceding the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thoma, Reto, Häuptle, Pirmin, Degen, Lukas, Bassetti, Stefano, Osthoff, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194184/ https://www.ncbi.nlm.nih.gov/pubmed/30364353 http://dx.doi.org/10.1093/omcr/omy084

Ejemplares similares

Risk factors and microbiological features of recurrent Escherichia coli bloodstream infections
por: Kim, Yong Chan, et al.
Publicado: (2023)

Homologous Escherichia coli Identified in Cerebrospinal Fluid and Bloodstream
por: Shi, Qingmiao, et al.
Publicado: (2021)

Analysis of early-onset bloodstream infection due to Escherichia coli infection in premature babies
por: Chen, I-Lun, et al.
Publicado: (2017)

Variation of Circulating Inflammatory Mediators in Staphylococcus aureus and Escherichia coli Bloodstream Infection
por: Duan, Jinyan, et al.
Publicado: (2016)

Colistin Resistance in Escherichia coli Isolates From Patients With Bloodstream Infection in Korea
por: Kim, Young Ah, et al.
Publicado: (2017)

Drug susceptibility and molecular epidemiology of Escherichia coli in bloodstream infections in Shanxi, China
por: Zhang, Yanjun, et al.
Publicado: (2021)

The bacterial genetic determinants of Escherichia coli capacity to cause bloodstream infections in humans
por: Burgaya, Judit, et al.
Publicado: (2023)

Probability of pharmacological target attainment with flucloxacillin in Staphylococcus aureus bloodstream infection: a prospective cohort study of unbound plasma and individual MICs
por: Moser, Stephan, et al.
Publicado: (2021)

Bloodstream infection due to Escherichia coli in liver cirrhosis patients: clinical features and outcomes
por: Tu, Bo, et al.
Publicado: (2017)

Population Dynamics of Escherichia coli Causing Bloodstream Infections over Extended Time Periods
por: Pitout, Johann D. D.
Publicado: (2021)

Mortality in Escherichia coli bloodstream infections: a multinational population-based cohort study
por: MacKinnon, Melissa C., et al.
Publicado: (2021)

The Characteristics of Extended-Spectrum β-Lactamases (ESBLs)-Producing Escherichia coli in Bloodstream Infection
por: Li, Rongrong, et al.
Publicado: (2023)

Complete Genome Sequences of Four Escherichia coli ST95 Isolates from Bloodstream Infections
por: Stephens, Craig M., et al.
Publicado: (2015)

Escherichia coli Bloodstream Infections in Patients at a University Hospital: Virulence Factors and Clinical Characteristics
por: Daga, Ana Paula, et al.
Publicado: (2019)

Identification of a novel sequence type of Escherichia coli as the causative agent of pyelonephritis and bloodstream infection
por: Mac Aogáin, Micheál, et al.
Publicado: (2016)

A prospective study of Escherichia coli bloodstream infection among adolescents and adults in northern Tanzania
por: Madut, Deng B, et al.
Publicado: (2020)

Genome-based characterization of Escherichia coli causing bloodstream infection through next-generation sequencing
por: Paramita, Rafika Indah, et al.
Publicado: (2020)

Clinical Analysis of Bloodstream Infection of Escherichia coli in Patients with Pancreatic Cancer from 2011 to 2019
por: Bai, Changsen, et al.
Publicado: (2022)

Bloodstream infection by mcr-1-harboring Escherichia coli in a cancer patient in southern Brazil
por: Lorenzoni, Vinícius Victor, et al.
Publicado: (2018)

Temporal dynamics of genetically heterogeneous extended-spectrum cephalosporin-resistant Escherichia coli bloodstream infections
por: Shropshire, William C., et al.
Publicado: (2023)

210. Evaluating the Costs of Escherichia coli Bloodstream Infections: A Population-Based Cohort Study
por: King, Teagan, et al.
Publicado: (2023)

Characteristics of Escherichia coli Urine Isolates and Risk Factors for Secondary Bloodstream Infections in Patients with Urinary Tract Infections
por: Choi, Hyeon Jin, et al.
Publicado: (2022)

Antimicrobial Resistance and Molecular Epidemiology of Escherichia coli Causing Bloodstream Infections in Three Hospitals in Shanghai, China
por: Wang, Su, et al.
Publicado: (2016)

Epidemiology of Bloodstream Infections Caused by Escherichia coli and Klebsiella pneumoniae That Are Piperacillin-Tazobactam-Nonsusceptible but Ceftriaxone-Susceptible
por: Baker, Thomas M, et al.
Publicado: (2018)

Economic Burden of Patients with Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli
por: Wang, Yuan, et al.
Publicado: (2020)

Antibiotic Resistance Profile and Diversity of Subtypes Genes in Escherichia coli Causing Bloodstream Infection in Northern Vietnam
por: Hung, Pham Ngoc, et al.
Publicado: (2019)

Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Patients with Liver Cirrhosis
por: Chen, Wen-Chi, et al.
Publicado: (2021)

Antimicrobial Resistance and Molecular Epidemiology of Escherichia coli From Bloodstream Infection in Shanghai, China, 2016–2019
por: Xiao, Shuzhen, et al.
Publicado: (2022)

Effect of temperature on Escherichia coli bloodstream infection in a nationwide population-based study of incidence and resistance
por: Feldman, Sarah F., et al.
Publicado: (2022)

Clinical Impact of Ceftriaxone Resistance in Escherichia coli Bloodstream Infections: A Multicenter Prospective Cohort Study
por: Tamma, Pranita D, et al.
Publicado: (2022)

Risk Factors for Bloodstream Infections Due to ESBL-Producing Escherichia coli, Klebsiella spp., and Proteus mirabilis
por: Vance, Mary Kathryn, et al.
Publicado: (2023)

Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia
por: Søgaard, Kirstine K., et al.
Publicado: (2021)

The rising tide of bloodstream infections with Actinomyces species: bimicrobial infection with Actinomyces odontolyticus and Escherichia coli in an intravenous drug user
por: Weiand, Daniel, et al.
Publicado: (2014)

Mortality and molecular epidemiology associated with extended-spectrum β-lactamase production in Escherichia coli from bloodstream infection
por: Leistner, Rasmus, et al.
Publicado: (2014)

Regional variations in fluoroquinolone non-susceptibility among Escherichia coli bloodstream infections within the Veterans Healthcare Administration
por: Livorsi, Daniel J., et al.
Publicado: (2016)

Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey
por: Trecarichi, Enrico Maria, et al.
Publicado: (2019)

Trend in Antibiotic Resistance of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli and Klebsiella Pneumoniae Bloodstream Infections
por: Bayraktar, Banu, et al.
Publicado: (2019)

Increasing incidence and antimicrobial resistance in Escherichia coli bloodstream infections: a multinational population-based cohort study
por: MacKinnon, Melissa C., et al.
Publicado: (2021)

Ten-year longitudinal molecular epidemiology study of Escherichia coli and Klebsiella species bloodstream infections in Oxfordshire, UK
por: Lipworth, Samuel, et al.
Publicado: (2021)

Escherichia coli bloodstream infections in the western interior of British Columbia, Canada: a population-based cohort study
por: MacKinnon, Melissa C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tts35t0vo8umr4u2nifgrjf5os